Department of Laboratory Medicine, Inje University College of Medicine, Busan 47392, Republic of Korea; Paik Institute for Clinical Research, Inje University College of Medicine, Busan 47392, Republic of Korea
Auto-generated profile, based on publicly available information
Kyungmin Lee
Department of Laboratory Medicine, Inje University College of Medicine, Busan 47392, Republic of Korea; Paik Institute for Clinical Research, Inje University College of Medicine, Busan 47392, Republic of Korea
Introduction.Streptococcus pneumoniaeis an important pathogen with high morbidity and mortality rates. The aim of this study was to evaluate the distribution of common serotypes and antimicrobial susceptibility ofS. pneumoniaein Korea.Methods. A total of 378 pneumococcal isolates were collected from 2008 through 2014. We analyzed the serotype and antimicrobial susceptibility for both invasive and noninvasive isolates.Results. Over the 7 years, 3 (13.5%), 35 (10.8%), 19A (9.0%), 19F (6.6%), 6A (6.1%), and 34 (5.6%) were common serotypes/serogroups. The vaccine coverage rates of PCV7, PCV10, PCV13, and PPSV23 were 21.4%, 23.3%, 51.9%, and 62.4% in all periods. The proportions of serotypes 19A and 19F decreased and nonvaccine serotypes increased between 2008 and 2010 and 2011 and 2014. Of 378S. pneumoniaeisolates, 131 (34.7%) were multidrug resistant (MDR) and serotypes 19A and 19F were predominant. The resistance rate to levofloxacin was significantly increased (7.2%).Conclusion. We found changes of pneumococcal serotype and antimicrobial susceptibility during the 7 years after introduction of the first pneumococcal vaccine. It is important to continuously monitor pneumococcal serotypes and their susceptibilities.